Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function

{ 'indexed': {'date-parts': [[2022, 9, 18]], 'date-time': '2022-09-18T05:22:38Z', 'timestamp': 1663478558909}, 'reference-count': 69, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2022, 9, 1]], 'date-time': '2022-09-01T00:00:00Z', 'timestamp': 1661990400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'content-domain': {'domain': ['elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2022, 9]]}, 'DOI': '10.1016/j.ejphar.2022.175267', 'type': 'journal-article', 'created': {'date-parts': [[2022, 9, 17]], 'date-time': '2022-09-17T12:30:13Z', 'timestamp': 1663417813000}, 'page': '175267', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells ' 'frequency and function', 'prefix': '10.1016', 'author': [ {'given': 'Sanaz', 'family': 'Abbaspour-Aghdam', 'sequence': 'first', 'affiliation': []}, {'given': 'Ali', 'family': 'Hazrati', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Samaneh', 'family': 'Abdolmohammadi-Vahid', 'sequence': 'additional', 'affiliation': []}, {'given': 'Safa', 'family': 'Tahmasebi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jafar', 'family': 'Mohseni', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hamed', 'family': 'Valizadeh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mehdi', 'family': 'Nadiri', 'sequence': 'additional', 'affiliation': []}, {'given': 'Haleh', 'family': 'Mikaeili', 'sequence': 'additional', 'affiliation': []}, {'given': 'Armin', 'family': 'Sadeghi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mehdi', 'family': 'Yousefi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Leila', 'family': 'Roshangar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Behzad', 'family': 'Nikzad', 'sequence': 'additional', 'affiliation': []}, {'given': 'Farhad', 'family': 'Jadidi-Niaragh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hossein Samadi', 'family': 'Kafil', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kosar', 'family': 'Malekpour', 'sequence': 'additional', 'affiliation': []}, {'given': 'Majid', 'family': 'Ahmadi', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.ejphar.2022.175267_bib1', 'first-page': '363', 'article-title': 'Anticancer potential of curcumin: preclinical and clinical studies', 'volume': '23', 'author': 'Aggarwal', 'year': '2003', 'journal-title': 'Anticancer Res.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib2', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.intimp.2019.105730', 'article-title': 'Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ' 'ratio: a double-blind, phase II randomized clinical trial', 'volume': '74', 'author': 'Ahmadi', 'year': '2019', 'journal-title': 'Int. Immunopharm.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib3', 'doi-asserted-by': 'crossref', 'first-page': '103', 'DOI': '10.1002/jcb.28901', 'article-title': 'The effects of nanocurcumin on Treg cell responses and treatment of ' 'ankylosing spondylitis patients: a randomized, double‐blind, ' 'placebo‐controlled clinical trial', 'volume': '121', 'author': 'Ahmadi', 'year': '2020', 'journal-title': 'J. Cell. Biochem.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib4', 'doi-asserted-by': 'crossref', 'first-page': '3985', 'DOI': '10.1002/jcp.27207', 'article-title': 'Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood ' "of patients with Behcet's disease", 'volume': '234', 'author': 'Ahmadi', 'year': '2019', 'journal-title': 'J. Cell. Physiol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib5', 'doi-asserted-by': 'crossref', 'first-page': '310', 'DOI': '10.1038/nri.2016.34', 'article-title': 'Emerging insights into natural killer cells in human peripheral tissues', 'volume': '16', 'author': 'Björkström', 'year': '2016', 'journal-title': 'Nat. Rev. Immunol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib6', 'doi-asserted-by': 'crossref', 'first-page': '176', 'DOI': '10.1016/j.coviro.2021.06.005', 'article-title': 'Natural killer cells and unconventional T cells in COVID-19', 'volume': '49', 'author': 'Björkström', 'year': '2021', 'journal-title': 'Curr. Opin. Virol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib7', 'doi-asserted-by': 'crossref', 'first-page': '147', 'DOI': '10.1007/978-1-4614-0106-3_9', 'article-title': 'Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in ' 'sepsis', 'volume': '946', 'author': 'Bosmann', 'year': '2012', 'journal-title': 'Adv. Exp. Med. Biol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib8', 'first-page': '146', 'article-title': 'Association of COVID-19 inflammation with activation of the C5a-C5aR1 ' 'axis', 'volume': '588', 'author': 'Carvelli', 'year': '2020', 'journal-title': 'Regular and young investigator award abstracts'}, { 'key': '10.1016/j.ejphar.2022.175267_bib9', 'doi-asserted-by': 'crossref', 'first-page': '25', 'DOI': '10.1016/j.cytogfr.2020.05.003', 'article-title': 'The cytokine storm in COVID-19: an overview of the involvement of the ' 'chemokine/chemokine-receptor system', 'volume': '53', 'author': 'Coperchini', 'year': '2020', 'journal-title': 'Cytokine Growth Factor Rev.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib10', 'doi-asserted-by': 'crossref', 'article-title': 'Math and aftermath of COVID-19 pandemic and its interrelationship from ' 'the resilience perspective', 'author': 'Ćurković', 'year': '2020', 'journal-title': 'J. Infect.', 'DOI': '10.1016/j.jinf.2020.06.020'}, { 'key': '10.1016/j.ejphar.2022.175267_bib11', 'doi-asserted-by': 'crossref', 'first-page': '5222', 'DOI': '10.1002/jcp.26301', 'article-title': 'Nanocurcumin restores aberrant miRNA expression profile in multiple ' 'sclerosis, randomized, double‐blind, placebo‐controlled trial', 'volume': '233', 'author': 'Dolati', 'year': '2018', 'journal-title': 'J. Cell. Physiol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib12', 'doi-asserted-by': 'crossref', 'first-page': '1158', 'DOI': '10.1016/j.pharep.2018.05.008', 'article-title': 'Nanocurcumin is a potential novel therapy for multiple sclerosis by ' 'influencing inflammatory mediators', 'volume': '70', 'author': 'Dolati', 'year': '2018', 'journal-title': 'Pharmacol. Rep.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib13', 'doi-asserted-by': 'crossref', 'first-page': '5106', 'DOI': '10.1002/jcp.27315', 'article-title': 'The imbalance of Th17/Treg axis involved in the pathogenesis of ' 'preeclampsia', 'volume': '234', 'author': 'Eghbal-Fard', 'year': '2019', 'journal-title': 'J. Cell. Physiol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib14', 'doi-asserted-by': 'crossref', 'first-page': '449', 'DOI': '10.1007/978-3-030-63761-3_26', 'article-title': 'Immune-based therapy for COVID-19', 'volume': '1318', 'author': 'Esmaeilzadeh', 'year': '2021', 'journal-title': 'Adv. Exp. Med. Biol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib15', 'doi-asserted-by': 'crossref', 'article-title': 'Recent advances in antibody-based immunotherapy strategies for COVID-19', 'author': 'Esmaeilzadeh', 'year': '2021', 'journal-title': 'J. Cell. Biochem.', 'DOI': '10.1002/jcb.30017'}, { 'key': '10.1016/j.ejphar.2022.175267_bib16', 'doi-asserted-by': 'crossref', 'first-page': '1792', 'DOI': '10.1002/cbin.11403', 'article-title': 'Lymphopenia in COVID‐19: therapeutic opportunities', 'volume': '44', 'author': 'Fathi', 'year': '2020', 'journal-title': 'Cell Biol. Int.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib17', 'first-page': '129', 'article-title': 'Curcuminoids and ω-3 fatty acids with anti-oxidants potentiate ' 'cytotoxicity of natural killer cells against pancreatic ductal ' 'adenocarcinoma cells and inhibit interferon γ production', 'volume': '6', 'author': 'Fiala', 'year': '2015', 'journal-title': 'Front. Physiol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib18', 'doi-asserted-by': 'crossref', 'first-page': '331', 'DOI': '10.1615/CritRevTherDrugCarrierSyst.2013007236', 'article-title': 'Nanocurcumin: a promising therapeutic advancement over native curcumin', 'volume': '30', 'author': 'Flora', 'year': '2013', 'journal-title': 'Crit. Rev. Ther. Drug Carrier Syst.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib19', 'doi-asserted-by': 'crossref', 'first-page': '5805', 'DOI': '10.4049/jimmunol.1100338', 'article-title': 'C5a regulates NKT and NK cell functions in sepsis', 'volume': '187', 'author': 'Fusakio', 'year': '2011', 'journal-title': 'J. Immunol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib20', 'article-title': 'Highly pathogenic coronavirus N protein aggravates lung injury by ' 'MASP-2-mediated complement over-activation', 'author': 'Gao', 'year': '2020', 'journal-title': 'medRxiv'}, { 'key': '10.1016/j.ejphar.2022.175267_bib21', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.lfs.2021.119503', 'article-title': 'Risk factors for adverse outcomes of COVID-19 patients: possible basis ' 'for diverse responses to the novel coronavirus SARS-CoV-2', 'volume': '277', 'author': 'Ghaebi', 'year': '2021', 'journal-title': 'Life Sci.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib22', 'doi-asserted-by': 'crossref', 'first-page': '111', 'DOI': '10.1016/j.fct.2015.05.022', 'article-title': 'The beneficial role of curcumin on inflammation, diabetes and ' 'neurodegenerative disease: a recent update', 'volume': '83', 'author': 'Ghosh', 'year': '2015', 'journal-title': 'Food Chem. Toxicol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib23', 'doi-asserted-by': 'crossref', 'first-page': '992', 'DOI': '10.1016/j.chom.2020.04.009', 'article-title': 'Complex immune dysregulation in COVID-19 patients with severe ' 'respiratory failure', 'volume': '27', 'author': 'Giamarellos-Bourboulis', 'year': '2020', 'journal-title': 'Cell Host Microbe'}, { 'key': '10.1016/j.ejphar.2022.175267_bib24', 'first-page': '1', 'article-title': 'The origin, transmission and clinical therapies on coronavirus disease ' '2019 (COVID-19) outbreak–an update on the status', 'volume': '7', 'author': 'Guo', 'year': '2020', 'journal-title': 'Mil. Med. Res.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib25', 'doi-asserted-by': 'crossref', 'first-page': '195', 'DOI': '10.1208/s12248-012-9432-8', 'article-title': 'Therapeutic roles of curcumin: lessons learned from clinical trials', 'volume': '15', 'author': 'Gupta', 'year': '2013', 'journal-title': 'AAPS J.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib26', 'doi-asserted-by': 'crossref', 'first-page': '12027', 'DOI': '10.1002/jcb.28488', 'article-title': 'Nanocurcumin: a novel strategy in treating ankylosing spondylitis by ' 'modulating Th17 cells frequency and function', 'volume': '120', 'author': 'Hajialilo', 'year': '2019', 'journal-title': 'J. Cell. Biochem.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib27', 'first-page': '282', 'article-title': 'Novel nanomicelle formulation to enhance bioavailability and stability ' 'of curcuminoids', 'volume': '22', 'author': 'Hatamipour', 'year': '2019', 'journal-title': 'Iran. J. Basic Med. Sci.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib28', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.msard.2020.102466', 'article-title': 'Changes in Th17 cells frequency and function after ozone therapy used ' 'to treat multiple sclerosis patients', 'volume': '46', 'author': 'Izadi', 'year': '2020', 'journal-title': 'Mult. Scler. Relat. Disord.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib29', 'doi-asserted-by': 'crossref', 'first-page': '487', 'DOI': '10.3389/fphar.2020.00487', 'article-title': 'Nanocurcumin: a promising candidate for therapeutic applications', 'volume': '11', 'author': 'Karthikeyan', 'year': '2020', 'journal-title': 'Front. Pharmacol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib30', 'series-title': 'New Look to Phytomedicine: Advancements in Herbal Products as Novel Drug ' 'Leads', 'author': 'Khan', 'year': '2018'}, { 'key': '10.1016/j.ejphar.2022.175267_bib31', 'doi-asserted-by': 'crossref', 'first-page': '1329', 'DOI': '10.31557/APJCP.2019.20.5.1329', 'article-title': 'The therapeutic and preventive efficacy of curcumin and its derivatives ' 'in esophageal cancer', 'volume': '20', 'author': 'Komal', 'year': '2019', 'journal-title': 'Asian Pac. J. Cancer Prev. APJCP'}, { 'key': '10.1016/j.ejphar.2022.175267_bib32', 'article-title': 'Integrated immune dynamics define correlates of COVID-19 severity and ' 'antibody responses. Cell reports', 'volume': '2', 'author': 'Koutsakos', 'year': '2021', 'journal-title': 'Medicine'}, { 'key': '10.1016/j.ejphar.2022.175267_bib33', 'doi-asserted-by': 'crossref', 'first-page': '874', 'DOI': '10.4014/jmb.1801.01074', 'article-title': 'Improved anti-cancer effect of curcumin on breast cancer cells by ' 'increasing the activity of natural killer cells', 'volume': '28', 'author': 'Lee', 'year': '2018', 'journal-title': 'J. Microbiol. Biotechnol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib34', 'doi-asserted-by': 'crossref', 'first-page': '113', 'DOI': '10.1016/B978-0-12-800173-8.00003-9', 'article-title': 'Curcumin', 'volume': '39', 'author': 'Lestari', 'year': '2014', 'journal-title': 'Profiles Drug Subst. Excipients Relat. Methodol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib35', 'doi-asserted-by': 'crossref', 'first-page': '20', 'DOI': '10.1002/ctm2.16', 'article-title': 'Acute lung injury in patients with COVID-19 infection', 'volume': '10', 'author': 'Li', 'year': '2020', 'journal-title': 'Clin. Transl. Med.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib36', 'doi-asserted-by': 'crossref', 'first-page': '20', 'DOI': '10.1002/ctm2.16', 'article-title': 'Acute lung injury in patients with COVID‐19 infection', 'volume': '10', 'author': 'Li', 'year': '2020', 'journal-title': 'Clin. Transl. Med.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib37', 'doi-asserted-by': 'crossref', 'first-page': '408', 'DOI': '10.1111/j.1365-2249.2004.02523.x', 'article-title': 'CD56+ dim and CD56+ bright cell activation and apoptosis in hepatitis C ' 'virus infection', 'volume': '137', 'author': 'Lin', 'year': '2004', 'journal-title': 'Clin. Exp. Immunol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib38', 'doi-asserted-by': 'crossref', 'first-page': '546', 'DOI': '10.1002/bmc.795', 'article-title': 'High-performance liquid chromatography analysis of curcumin in rat ' 'plasma: application to pharmacokinetics of polymeric micellar ' 'formulation of curcumin', 'volume': '21', 'author': 'Ma', 'year': '2007', 'journal-title': 'Biomed. Chromatogr. : BMC (Biomed. Chromatogr.)'}, { 'key': '10.1016/j.ejphar.2022.175267_bib39', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fimmu.2020.01512', 'article-title': 'Flattening the COVID-19 curve with natural killer cell based ' 'immunotherapies', 'volume': '11', 'author': 'Market', 'year': '2020', 'journal-title': 'Front. Immunol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib40', 'doi-asserted-by': 'crossref', 'article-title': 'COVID-19: our current knowledge of epidemiology, pathology, therapeutic ' 'approaches, and diagnostic methods', 'author': 'Marofi', 'year': '2021', 'journal-title': 'Anti Cancer Agents Med. Chem.', 'DOI': '10.2174/1871520621666210201101245'}, { 'key': '10.1016/j.ejphar.2022.175267_bib41', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.clim.2020.108598', 'article-title': 'Complement C3 vs C5 inhibition in severe COVID-19: early clinical ' 'findings reveal differential biological efficacy', 'volume': '220', 'author': 'Mastellos', 'year': '2020', 'journal-title': 'Clin. Immunol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib42', 'volume': 'vol. 5', 'author': 'Maucourant', 'year': '2020'}, { 'key': '10.1016/j.ejphar.2022.175267_bib43', 'doi-asserted-by': 'crossref', 'first-page': '2801', 'DOI': '10.1021/mp300075u', 'article-title': 'Sustained wound healing activity of curcumin loaded oleic acid based ' 'polymeric bandage in a rat model', 'volume': '9', 'author': 'Mohanty', 'year': '2012', 'journal-title': 'Mol. Pharm.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib44', 'doi-asserted-by': 'crossref', 'first-page': '151', 'DOI': '10.1016/j.jbiotec.2004.06.007', 'article-title': 'Challenges and solutions for the delivery of biotech drugs--a review of ' 'drug nanocrystal technology and lipid nanoparticles', 'volume': '113', 'author': 'Muller', 'year': '2004', 'journal-title': 'J. Biotechnol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib45', 'doi-asserted-by': 'crossref', 'first-page': '399', 'DOI': '10.1089/ars.2006.1479', 'article-title': "Mitochondrial complex I inhibition in Parkinson's disease: how can " 'curcumin protect mitochondria?', 'volume': '9', 'author': 'Mythri', 'year': '2007', 'journal-title': 'Antioxidants Redox Signal.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib46', 'doi-asserted-by': 'crossref', 'first-page': '5035', 'DOI': '10.1182/bloodadvances.2020002650', 'article-title': 'Impaired natural killer cell counts and cytolytic activity in patients ' 'with severe COVID-19', 'volume': '4', 'author': 'Osman', 'year': '2020', 'journal-title': 'Blood Adv.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib47', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.intimp.2020.107225', 'article-title': 'The deregulated immune reaction and cytokines release storm (CRS) in ' 'COVID-19 disease', 'volume': '90', 'author': 'Pasrija', 'year': '2021', 'journal-title': 'Int. Immunopharm.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib48', 'first-page': '567', 'article-title': 'The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid ' 'profile in diabetic subjects: a randomized clinical trial', 'volume': '6', 'author': 'Rahimi', 'year': '2016', 'journal-title': 'Avicenna J. Phytomed.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib49', 'doi-asserted-by': 'crossref', 'first-page': '343', 'DOI': '10.1038/s41577-020-0320-7', 'article-title': 'Complement as a target in COVID-19?', 'volume': '20', 'author': 'Risitano', 'year': '2020', 'journal-title': 'Nat. Rev. Immunol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib50', 'doi-asserted-by': 'crossref', 'first-page': '2829', 'DOI': '10.1002/jcp.30047', 'article-title': 'Th17 and Treg cells function in SARS‐CoV2 patients compared with ' 'healthy controls', 'volume': '236', 'author': 'Sadeghi', 'year': '2021', 'journal-title': 'J. Cell. Physiol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib51', 'doi-asserted-by': 'crossref', 'first-page': '1589', 'DOI': '10.1002/jmv.26505', 'article-title': 'Apoptosis and immunophenotyping of peripheral blood lymphocytes in ' 'Iranian COVID‐19 patients: clinical and laboratory characteristics', 'volume': '93', 'author': 'Taghiloo', 'year': '2021', 'journal-title': 'J. Med. Virol.'}, { 'issue': '7', 'key': '10.1016/j.ejphar.2022.175267_bib52', 'doi-asserted-by': 'crossref', 'first-page': '5325', 'DOI': '10.1002/jcp.30233', 'article-title': 'Immunomodulatory effects of Nanocurcumin on Th17 cell responses in mild ' 'and severe COVID‐19 patients', 'volume': '236', 'author': 'Tahmasebi', 'year': '2021', 'journal-title': 'J. Cell. Physiol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib53', 'doi-asserted-by': 'crossref', 'first-page': '9211', 'DOI': '10.1002/jcp.29804', 'article-title': 'The outlook for diagnostic purposes of the 2019-novel coronavirus ' 'disease', 'volume': '235', 'author': 'Tahmasebi', 'year': '2020', 'journal-title': 'J. Cell. Physiol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib54', 'doi-asserted-by': 'crossref', 'article-title': 'The effects of Oxygen‐Ozone therapy on regulatory T‐cell responses in ' 'multiple sclerosis patients', 'author': 'Tahmasebi', 'year': '2021', 'journal-title': 'Cell Biol. Int.', 'DOI': '10.1002/cbin.11589'}, { 'key': '10.1016/j.ejphar.2022.175267_bib55', 'series-title': 'Nanocurcumin Improves Treg Cell Responses in Patients with Mild and ' 'Severe SARS-CoV2', 'author': 'Tahmasebi', 'year': '2021'}, { 'key': '10.1016/j.ejphar.2022.175267_bib56', 'doi-asserted-by': 'crossref', 'first-page': '609', 'DOI': '10.1007/s10787-017-0395-3', 'article-title': 'Immunomodulatory potential of nanocurcumin-based formulation', 'volume': '25', 'author': 'Trivedi', 'year': '2017', 'journal-title': 'Inflammopharmacology'}, { 'key': '10.1016/j.ejphar.2022.175267_bib57', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.intimp.2020.107088', 'article-title': 'Nano-curcumin therapy, a promising method in modulating inflammatory ' 'cytokines in COVID-19 patients', 'volume': '89', 'author': 'Valizadeh', 'year': '2020', 'journal-title': 'Int. Immunopharm.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib58', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.intimp.2020.107088', 'article-title': 'Nano-curcumin therapy, a promising method in modulating inflammatory ' 'cytokines in COVID-19 patients', 'volume': '89', 'author': 'Valizadeh', 'year': '2020', 'journal-title': 'Int. Immunopharm.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib59', 'doi-asserted-by': 'crossref', 'first-page': '6351', 'DOI': '10.3390/ijms21176351', 'article-title': 'Natural killer cell dysfunction and its role in COVID-19', 'volume': '21', 'author': 'van Eeden', 'year': '2020', 'journal-title': 'Int. J. Mol. Sci.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib60', 'doi-asserted-by': 'crossref', 'first-page': '963', 'DOI': '10.1038/s41436-020-01077-7', 'article-title': 'Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants ' 'are risk factors for severe COVID-19', 'volume': '23', 'author': 'Vietzen', 'year': '2021', 'journal-title': 'Genet. Med.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib61', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105948', 'article-title': 'Review of the 2019 novel coronavirus (SARS-CoV-2) based on current ' 'evidence', 'volume': '55', 'author': 'Wang', 'year': '2020', 'journal-title': 'Int. J. Antimicrob. Agents'}, { 'key': '10.1016/j.ejphar.2022.175267_bib62', 'first-page': '1070', 'volume': '26', 'author': 'Wilk', 'year': '2020', 'journal-title': 'A single-cell atlas of the peripheral immune response in patients with ' 'severe COVID-19'}, { 'key': '10.1016/j.ejphar.2022.175267_bib63', 'doi-asserted-by': 'crossref', 'first-page': '44', 'DOI': '10.1016/j.ijid.2020.03.004', 'article-title': 'The SARS-CoV-2 outbreak: what we know', 'volume': '94', 'author': 'Wu', 'year': '2020', 'journal-title': 'Int. J. Infect. Dis.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib64', 'doi-asserted-by': 'crossref', 'first-page': '485', 'DOI': '10.1080/08923970500242244', 'article-title': 'Immunomodulatory effects of curcumin', 'volume': '27', 'author': 'Yadav', 'year': '2005', 'journal-title': 'Immunopharmacol. Immunotoxicol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib65', 'doi-asserted-by': 'crossref', 'first-page': '368', 'DOI': '10.3389/fimmu.2012.00368', 'article-title': 'New insights for C5a and C5a receptors in sepsis', 'volume': '3', 'author': 'Yan', 'year': '2012', 'journal-title': 'Front. Immunol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib66', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/ijerph17072323', 'article-title': 'The first 75 Days of novel coronavirus (SARS-CoV-2) outbreak: recent ' 'advances, prevention, and treatment', 'volume': '17', 'author': 'Yan', 'year': '2020', 'journal-title': 'Int. J. Environ. Res. Publ. Health'}, { 'key': '10.1016/j.ejphar.2022.175267_bib67', 'doi-asserted-by': 'crossref', 'first-page': '1678', 'DOI': '10.7150/ijbs.45053', 'article-title': 'SARS-CoV-2: an emerging coronavirus that causes a global threat', 'volume': '16', 'author': 'Zheng', 'year': '2020', 'journal-title': 'Int. J. Biol. Sci.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib68', 'doi-asserted-by': 'crossref', 'first-page': '533', 'DOI': '10.1038/s41423-020-0402-2', 'article-title': 'Functional exhaustion of antiviral lymphocytes in COVID-19 patients', 'volume': '17', 'author': 'Zheng', 'year': '2020', 'journal-title': 'Cell. Mol. Immunol.'}, { 'key': '10.1016/j.ejphar.2022.175267_bib69', 'doi-asserted-by': 'crossref', 'first-page': '533', 'DOI': '10.1038/s41423-020-0402-2', 'article-title': 'Functional exhaustion of antiviral lymphocytes in COVID-19 patients', 'volume': '17', 'author': 'Zheng', 'year': '2020', 'journal-title': 'Cell. Mol. Immunol.'}], 'container-title': 'European Journal of Pharmacology', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0014299922005283?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0014299922005283?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2022, 9, 17]], 'date-time': '2022-09-17T12:31:00Z', 'timestamp': 1663417860000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0014299922005283'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 9]]}, 'references-count': 69, 'alternative-id': ['S0014299922005283'], 'URL': 'http://dx.doi.org/10.1016/j.ejphar.2022.175267', 'relation': {}, 'ISSN': ['0014-2999'], 'subject': ['Pharmacology'], 'container-title-short': 'European Journal of Pharmacology', 'published': {'date-parts': [[2022, 9]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural ' 'killer cells frequency and function', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'European Journal of Pharmacology', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.ejphar.2022.175267', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, {'value': '© 2022 Published by Elsevier B.V.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '175267'}